UTHR vs. MRVL
UTHR (United Therapeutics Corporation) and MRVL (Marvell Technology, Inc.) are both stocks. UTHR operates in Biotechnology (Healthcare), while MRVL operates in Semiconductors (Technology). Over the past 10 years, UTHR returned 17.20%/yr vs 41.26%/yr for MRVL. At a 0.23 correlation, their price movements are largely independent.
Performance
UTHR vs. MRVL - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, UTHR achieves a 11.79% return, which is significantly lower than MRVL's 240.32% return. Over the past 10 years, UTHR has underperformed MRVL with an annualized return of 17.20%, while MRVL has yielded a comparatively higher 41.26% annualized return.
UTHR
- 1D
- -0.94%
- 1M
- -3.58%
- YTD
- 11.79%
- 6M
- 13.59%
- 1Y
- 67.18%
- 3Y*
- 33.59%
- 5Y*
- 25.53%
- 10Y*
- 17.20%
MRVL
- 1D
- 9.63%
- 1M
- 69.78%
- YTD
- 240.32%
- 6M
- 214.35%
- 1Y
- 323.75%
- 3Y*
- 69.41%
- 5Y*
- 42.37%
- 10Y*
- 41.26%
UTHR vs. MRVL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
UTHR United Therapeutics Corporation | 11.79% | 38.09% | 60.46% | -20.93% | 28.70% | 42.35% | 72.33% | -19.12% | -26.39% | 3.15% |
MRVL Marvell Technology, Inc. | 240.32% | -22.82% | 83.79% | 63.68% | -57.48% | 84.62% | 80.25% | 65.74% | -23.62% | 56.89% |
Correlation
The correlation between UTHR and MRVL is 0.06, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.06 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.07 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.10 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.18 |
Correlation (All Time) Calculated using the full available price history since Jun 30, 2000 | 0.23 |
The correlation between UTHR and MRVL shifts across timeframes, from 0.06 (1 year) to 0.23 (all time), reflecting how their relationship changes across market environments.
Fundamentals
UTHR:
$25.71B
MRVL:
$258.03B
UTHR:
$27.00
MRVL:
$2.90
UTHR:
20.17
MRVL:
99.74
UTHR:
0.66
MRVL:
0.18
UTHR:
8.19
MRVL:
28.91
UTHR:
4.36
MRVL:
14.17
UTHR:
$3.17B
MRVL:
$8.72B
UTHR:
$2.74B
MRVL:
$4.41B
UTHR:
$1.75B
MRVL:
$4.27B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
UTHR vs. MRVL — Risk / Return Rank
UTHR
MRVL
UTHR vs. MRVL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for United Therapeutics Corporation (UTHR) and Marvell Technology, Inc. (MRVL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| UTHR | MRVL | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -3.34 | ||
| Sortino ratioReturn per unit of downside risk | -1.52 | ||
| Omega ratioGain probability vs. loss probability | 1.37 | 1.59 | -0.22 |
| Calmar ratioReturn relative to maximum drawdown | 4.13 | 12.37 | -8.24 |
| Martin ratioReturn relative to average drawdown | 10.54 | 28.64 | -18.10 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| UTHR | MRVL | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.36 | 4.70 | -3.34 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.73 | 0.69 | +0.04 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.49 | 0.80 | -0.31 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.38 | 0.23 | +0.15 |
Drawdowns
UTHR vs. MRVL - Drawdown Comparison
The maximum UTHR drawdown since its inception was -93.18%, roughly equal to the maximum MRVL drawdown of -91.60%. Use the drawdown chart below to compare losses from any high point for UTHR and MRVL.
Loading charts...
Drawdown Indicators
| UTHR | MRVL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -93.18% | -91.60% | -1.58% |
Max Drawdown (1Y)Largest decline over 1 year | -16.35% | -26.36% | +10.01% |
Max Drawdown (3Y)Largest decline over 3 years | -33.00% | -60.79% | +27.79% |
Max Drawdown (5Y)Largest decline over 5 years | -33.00% | -61.88% | +28.88% |
Max Drawdown (10Y)Largest decline over 10 years | -55.56% | -61.88% | +6.32% |
Current DrawdownCurrent decline from peak | -8.73% | -8.72% | -0.01% |
Average DrawdownAverage peak-to-trough decline | -35.31% | -46.77% | +11.46% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.39% | 11.37% | -4.98% |
Volatility
UTHR vs. MRVL - Volatility Comparison
The current volatility for United Therapeutics Corporation (UTHR) is 5.15%, while Marvell Technology, Inc. (MRVL) has a volatility of 38.50%. This indicates that UTHR experiences smaller price fluctuations and is considered to be less risky than MRVL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| UTHR | MRVL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.15% | 38.50% | -33.35% |
Volatility (6M)Calculated over the trailing 6-month period | 26.01% | 54.32% | -28.31% |
Volatility (1Y)Calculated over the trailing 1-year period | 49.84% | 69.56% | -19.72% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 35.13% | 61.51% | -26.38% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 35.07% | 51.77% | -16.70% |
Dividends
UTHR vs. MRVL - Dividend Comparison
UTHR has not paid dividends to shareholders, while MRVL's dividend yield for the trailing twelve months is around 0.08%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
MRVL Marvell Technology, Inc. | 0.08% | 0.28% | 0.22% | 0.40% | 0.65% | 0.21% | 0.50% | 0.90% | 1.48% | 1.12% | 1.73% | 2.72% |
UTHR United Therapeutics Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
UTHR vs. MRVL - Financials Comparison
This section allows you to compare key financial metrics between United Therapeutics Corporation and Marvell Technology, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
UTHR vs. MRVL - Profitability Comparison
UTHR - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, United Therapeutics Corporation reported a gross profit of 648.10M and revenue of 781.50M. Therefore, the gross margin over that period was 82.9%.
MRVL - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Marvell Technology, Inc. reported a gross profit of 1.26B and revenue of 2.42B. Therefore, the gross margin over that period was 52.2%.
UTHR - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, United Therapeutics Corporation reported an operating income of 325.80M and revenue of 781.50M, resulting in an operating margin of 41.7%.
MRVL - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Marvell Technology, Inc. reported an operating income of 339.40M and revenue of 2.42B, resulting in an operating margin of 14.0%.
UTHR - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, United Therapeutics Corporation reported a net income of 274.90M and revenue of 781.50M, resulting in a net margin of 35.2%.
MRVL - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Marvell Technology, Inc. reported a net income of 34.50M and revenue of 2.42B, resulting in a net margin of 1.4%.
Frequently Asked Questions
UTHR and MRVL have a correlation of 0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
MRVL has higher volatility (38.50%) compared to UTHR (5.15%). In terms of maximum drawdown, UTHR dropped -93.18% vs MRVL's -91.60%.
MRVL currently has the higher Sharpe Ratio (4.70 vs 1.36), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for UTHR and MRVL
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer